Study: NCT00874939

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil 5mg
Description: One 5 mg tablet, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil 5mg
Description: One 5 mg tablet, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil 5mg
Description: One 5 mg tablet, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil 5mg
Description: One 5 mg tablet, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil 5mg
Description: One 5 mg tablet, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil 5mg
Description: One 5 mg tablet, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil 5mg
Description: One 5 mg tablet, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-0249
Description: Five tablets, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Donepezil
Description: One over-encapsulated capsule, single oral dose during each crossover period